Samsung Medical Center
| Republik Korea | Türkei | Österreich | |
| Protonenstrahltherapie | von $22,000 | von $70,000 | von $80,000 |
| Hochintensive fokussierte Ultraschallablation (HIFU) | von $12,500 | von $4,000 | von $12,000 |
| CyberKnife | von $11,500 | von $4,750 | von $50,000 |
| Chemotherapie bei Brustkrebs | von $19,200 | von $1,200 | von $15,000 |
| Strahlentherapie bei Sarkomen | - | von $3,250 | von $18,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Leiomyosarkom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Leiomyosarkom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Leiomyosarkom-Behandlungsreise nie allein.
Leading South Korean hospitals in Seoul provide dedicated leiomyosarcoma care through specialized musculoskeletal or sarcoma tumor centers. These JCI-accredited institutions utilize multidisciplinary teams including surgical oncologists and radiologists. Facilities like Seoul National University Hospital and Asan Medical Center manage high volumes of rare soft-tissue tumors using digitalized safety systems.
Bookimed Expert Insight: While many tertiary hospitals offer oncology, true leiomyosarcoma expertise is concentrated in facilities performing over 30,000 annual operations. Seoul National University Bundang Hospital uses the BESTcare digital system specifically to reduce medical errors. This is crucial for leiomyosarcoma because complex staging and pathology re-reviews often change treatment plans.
Patient Consensus: Patients emphasize seeking large tertiary centers in Seoul to ensure pathology slides are re-reviewed by sarcoma-specific specialists. It is important to confirm the hospital has a dedicated tumor board for combined decision-making.
Confirming leiomyosarcoma after a biopsy in Korea requires a secondary pathology review and immunohistochemistry (IHC) staining. Specialist pathologists identify smooth muscle markers like SMA, desmin, and h-Caldesmon. Leading Seoul-based tertiary centers often perform histological revisions to differentiate these tumors from other spindle cell cancers.
Bookimed Expert Insight: While many clinics offer biopsies, the confirmation phase in Korea often involves a formal histopathology revision. This is crucial because leiomyosarcoma is frequently misclassified. Patients should note that major centers like Asan Medical Center perform over 65,000 operations annually. This high volume gives their pathology departments superior expertise in recognizing rare sarcoma subtypes that smaller clinics might miss.
Patient Consensus: Patients note that an initial biopsy is rarely the final word. Many recommend sending tissue samples to a large university hospital in Seoul for a second opinion to ensure the diagnosis is definitive before starting intensive treatment.
Specialists in South Korea primarily treat localized leiomyosarcoma with complete surgical resection. High-volume tertiary centers in Seoul utilize multidisciplinary teams for this aggressive cancer. Doctors often combine surgery with radiation or chemotherapy to manage advanced cases. Newer technologies like heavy ion therapy and proton-beam therapy target treatment-resistant tumors.
Bookimed Expert Insight: Patient data shows that choosing a hospital that treats over 1,000,000 patients annually is vital for rare sarcomas. Asan Medical Center performs over 65,000 operations yearly. This high volume leads to better outcomes in complex resections. Most top-rated Korean clinics also hold Joint Commission International accreditation. This confirms they meet global safety standards for aggressive oncology cases.
Patient Consensus: Patients note that getting an expert pathology review is essential before starting any treatment. Many find that surgery is more central to the plan than they initially expected.
Advanced targeted therapies for recurrent or metastatic leiomyosarcoma include tyrosine kinase inhibitors and drug-based immunotherapy. Specialized centers in South Korea utilize molecular profiling to identify specific mutations. These therapies generally follow standard chemotherapy failure, focusing on angiogenesis and DNA repair pathways.
Bookimed Expert Insight: Data shows South Korean institutions like Samsung Medical Center and Asan Medical Center handle massive patient volumes, exceeding 100,000 oncology cases annually. This volume is key for leiomyosarcoma. Since individual mutations are rare, high-capacity centers are more likely to have active clinical trials for niche molecular profiles. These digital hospitals use advanced systems to match your genomic data with available experimental protocols faster than smaller facilities.
Patient Consensus: Patients emphasize asking for next-generation sequencing early to confirm eligibility for targeted trials. Many note that consulting a sarcoma specialist at a major academic hospital is vital for accessing newer systemic drugs.
South Korea offers proton therapy for leiomyosarcoma at major oncology centers in Seoul. Facilities like Samsung Medical Center provide this precise radiation. It targets tumors near critical organs while sparing healthy tissue. Accreditation from JCI or KOIHA ensures treatment meets international safety standards.
Bookimed Expert Insight: While many think proton therapy is a universal solution, Korean specialists typically reserve it for retroperitoneal or spinal sarcomas. Data from intensive centers like Asan Medical Center, performing 65,000+ operations yearly, suggests combining technologies is key. Clinics often pair robotic surgery with targeted radiation to maximize success in sensitive anatomical areas.
Patient Consensus: Patients note that proton therapy is a location-dependent tool rather than a standard choice for all leiomyosarcoma cases. Many recommend getting a specialist review to confirm if the tumor’s position justifies the high-tech treatment before traveling.
Medical tourists should plan for a total stay of 14 to 28 days for leiomyosarcoma surgery in South Korea. This timeframe includes pre-operative consultations and surgical staging. It also covers initial inpatient recovery and post-operative monitoring at Seoul centers before international travel.
Bookimed Expert Insight: Korea University Anam Hospital specializes in robotic surgery and minimal blood transfusions to speed recovery. Our data indicates that digitalized centers like Seoul National University Bundang Hospital (SNUBH) streamline pre-operative staging. This efficient testing helps patients move from initial consultation to the operating room faster than in many other countries.
Patient Consensus: Patients emphasize the need for a 3-week planning window to accommodate unexpected pathology findings. They note that staying until mobile and cleared for long-haul flights is more important than a fixed date.
Top sarcoma centers in South Korea provide extensive English-language support through dedicated international healthcare centers. Facilities like Severance Hospital and Asan Medical Center employ specialized coordinators. These experts manage medical documentation, scheduling, and real-time interpretation during oncology consultations for complex cases like leiomyosarcoma.
Bookimed Expert Insight: Clinical volume is a reliable proxy for language infrastructure in South Korea. Clinics serving over 1,000,000 patients annually, such as Seoul National University Hospital, invest heavily in digital systems like BESTcare. These platforms streamline coordination for international patients from the USA and UAE, ensuring smoother transitions between diagnostic imaging and surgical planning.
Patient Consensus: Patients note that while registration and billing are seamless in English, having a dedicated medical interpreter is vital for discussing technical treatment plans and recurrence risks. Most emphasize that major university hospitals offer the most reliable translation services for complex oncology journeys.